PTC Therapeutics Inc (PTCT)
43.86
+0.97
(+2.26%)
USD |
NASDAQ |
Nov 22, 14:18
PTC Therapeutics Total Assets (Quarterly): 1.842B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.842B |
| June 30, 2024 | 1.916B |
| March 31, 2024 | 1.790B |
| December 31, 2023 | 1.896B |
| September 30, 2023 | 1.260B |
| June 30, 2023 | 1.338B |
| March 31, 2023 | 1.609B |
| December 31, 2022 | 1.706B |
| September 30, 2022 | 1.576B |
| June 30, 2022 | 1.804B |
| March 31, 2022 | 1.800B |
| December 31, 2021 | 1.938B |
| September 30, 2021 | 2.007B |
| June 30, 2021 | 2.059B |
| March 31, 2021 | 2.112B |
| December 31, 2020 | 2.208B |
| September 30, 2020 | 2.181B |
| June 30, 2020 | 1.477B |
| March 31, 2020 | 1.546B |
| December 31, 2019 | 1.624B |
| September 30, 2019 | 1.641B |
| June 30, 2019 | 1.292B |
| March 31, 2019 | 1.284B |
| December 31, 2018 | 1.119B |
| Date | Value |
|---|---|
| September 30, 2018 | 1.029B |
| June 30, 2018 | 511.77M |
| March 31, 2018 | 379.41M |
| December 31, 2017 | 391.65M |
| September 30, 2017 | 367.72M |
| June 30, 2017 | 383.08M |
| March 31, 2017 | 248.64M |
| December 31, 2016 | 269.34M |
| September 30, 2016 | 288.18M |
| June 30, 2016 | 305.56M |
| March 31, 2016 | 335.23M |
| December 31, 2015 | 365.28M |
| September 30, 2015 | 396.10M |
| June 30, 2015 | 273.82M |
| March 31, 2015 | 299.52M |
| December 31, 2014 | 333.22M |
| September 30, 2014 | 220.80M |
| June 30, 2014 | 237.56M |
| March 31, 2014 | 255.84M |
| December 31, 2013 | 151.90M |
| September 30, 2013 | 167.24M |
| June 30, 2013 | 175.47M |
| March 31, 2013 | 64.41M |
| December 31, 2012 | 13.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.260B
Minimum
Sep 2023
2.208B
Maximum
Dec 2020
1.784B
Average
1.802B
Median
Total Assets (Quarterly) Benchmarks
| ClearPoint Neuro Inc | 40.19M |
| Pfizer Inc | 219.48B |
| Vertex Pharmaceuticals Inc | 22.24B |
| BridgeBio Pharma Inc | 664.98M |
| Cassava Sciences Inc | 223.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.897B |
| Shareholders Equity (Quarterly) | -1.054B |
| Debt to Equity Ratio | -0.2704 |
| Current Ratio | 2.098 |
| Net Debt Paydown Yield | 2.01% |